logo
Sign InSign Up

BECTON DICKINSON & CO (BDX)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for BDX, sign up here.

Income Statement

Revenue

$19.5bn

Gross Profit

$8.1bn

Earning before Tax

$1.5bn

Net Income

$1.3bn

Net Income Common Shareholders

$1.2bn

EPS

4.23

Balance Sheet

Cash

$1.2bn

Debt

$16.1bn

Assets

$52.3bn

Liabilities

$26.9bn

Equity

$25.3bn

Enterprise Value

$85.2bn

Cash Flow Statement

Net Cash from Operations

$3.4bn

Net Cash from Investing

$-0.7bn

Net Cash from Financing

$-2.3bn

Net Cash Flow

$490.0m

Free Cash Flow

$2.6bn

Free Cash Flow per Share

$9.12

Metrics

Price to Equity

58.09

Price to Equity (Damodaran)

57.64

Price to Book

2.79

Net Margin

0.06

Return on Equity

0.05

Return on Sales

0.10

Get immediate access to 5-years of reference grade data for BDX for free.

Sign up

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Company Info

Industry

Medical Instruments & Supplies

Employees

73,000

Address

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States

Phone

201 847 6800

Last Updated

2024-02-08

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy